2020 Partnership and Innovation Accelerator Pilot Grant Program
|
|
|
|
2020 PIAP Grant Program Application Is Now Open!
PIAP grants are one-year competitive awards to facilitate
collaborations between academic researchers from Rutgers University, Princeton University, and/or New Jersey Institute of Technology with community organizations so they can work together on health research that benefits our communities.
Click here to apply
.
Don’t have a community partner?
Click here
for a referral to a community organization in our Network of Networks.
|
|
2020 PIAP Program Webinar
Tune in on
July 8, 2020, from 1:30 pm-3:00 pm
, for the 2020 PIAP webinar.
Topics will include:
- Application process and deadlines
- Defining community partnerships
- Regulatory approvals
- Review process
- Q&A
Registration is required to participate in the webinar. To register for the program and submit your questions,
click here
.
|
|
|
|
|
Virtual Community Engagement Salon
The NJ ACTS CEC Virtual Community Engagement Salons bring researchers together with patients, community members and health care stakeholders to actively participate in cross-talk — to incubate ideas for engagement in the Patient-Centered Outcomes Research (PCOR) process from the planning stage through implementation and dissemination. It provides a forum for generating research questions, identifying evidence gaps and defining outcomes meaningful to patients. If you are interested in participating in a Salon, please contact our team using the
consult form
.
|
|
Consultations and Referrals
The Community Engagement Core will continue to host consultations and manage community referrals virtually.
We offer a variety of project-specific consultation services to enhance research design, implementation, and dissemination. To learn more and have consult,
submit a request
.
The core also helps facilitate working relationships between researchers and community stakeholders.To connect with a community organization,
please click here
.
|
|
|
|
|
If your research has benefited from one or more NJ ACTS resources, please remember to:
- Cite our CTSA grant, UL1TR003017, KL2TR003018, or TL1TR003019 in any relevant publications, abstracts, chapters, and/or posters.
- Submit your publications to PubMed Central (PMC) for compliance with the NIH Public Access Policy
- Share your research updates with us by sending an email to: njactscommunity@rwjms.rutgers.edu
|
|
Rutgers’ GSAPP Offers New Mental Health and Autism Support Services
More than 180 volunteer
licensed mental health providers, including faculty, staff, and alumni from GSAPP, as well as other licensed professionals, are offering mental health and autism services to those with or without insurance through the recently created
Psychological Services Network
.
The program is available to Rutgers students, faculty, staff, health care workers, families affected by Autism Spectrum Disorder (ASD) and all community members throughout New Jersey.
Learn more
.
|
|
|
|
|
COVID-19′s silent spread: Princeton researchers explore how symptomless transmission helps pathogens thrive
COVID-19′s rapid spread throughout the world has been fueled in part by the virus’ ability to be transmitted by people who are not showing symptoms of infection. Now, a study by researchers at Princeton has found that this silent phase of transmission can be a successful evolutionary strategy for pathogens such as viruses like the one that causes COVID-19. The
study
was published May 8 in the Journal Proceedings of the National Academy of Sciences. To read the
full story
.
|
|
With an NSF RAPID Grant, NJIT Engineers Build a New Model to Track COVID-19
A team of environmental engineers at NJIT is developing a new way to track the spread of SARS-CoV-2, the novel coronavirus, by combining advanced statistical methods with models that incorporate environmental conditions, such as wind speed, temperature and social distancing.
|
|
|
Just for the Health of It!
Just for the Health of It
is a proprietary health literacy program developed by the East Brunswick Public Library to promote health literacy in Middlesex County, New Jersey. The program aims to promote better health outcomes among all groups with a special emphasis on the poor, elderly, and new immigrants.
The program received an award from the New Jersey Hospital Association in 2017 and the following year was recognized by Library Journal as a model program on how public libraries can create healthy communities. The program received a grant from New Jersey Health Initiatives of the Robert Wood Johnson Foundation in 2019 to expand the program throughout Middlesex County as part of a broader statewide initiative to build and maintain a culture of health in New Jersey.
Learn more
.
|
|
|
|
|
The situation around the current spread of COVID-19 is changing rapidly. We have compiled resource links for the general community highlighting local resources across New Jersey, ways to get involved, and mental and physical wellness. Visit our COVID-19 page for resources for
individuals
and
community partners
.
Check out our
YouTube channel
and
blog
to stay up to date with COVID-19 related news across the consortium.
|
|
Rutgers Translates COVID-19 Information for New Jersey’s Diverse Population
|
|
|
COVID-19 Research Studies
|
|
The New Jersey Alliance for Clinical and Translational Science compiled resources for translating COVID-19 from bench to bedside.
Visit the site
. T
o learn more about funding opportunities and innovation challenges to assist the academic research community in mitigating COVID-19,
click here
.
Check out the COVID-19 related research across the consortium.
Rutgers Leads Clinical Trial of Drug to Prevent Cytokine Storms.
Rutgers has launched a clinical trial to test the safety and efficacy of an oral anti-inflammatory drug that could help prevent serious illness and death in early-stage COVID-19 patients. The drug, EDP1815, developed by Evelo Biosciences Inc., will be given to newly hospitalized COVID-19 patients at Robert Wood Johnson University Hospital to determine if it can regulate the onslaught of cytokine proteins – which cause the immune system to malfunction and become deadly – and is the reason for severe cases of respiratory distress and death. The trial is led by Reynold Panettieri Jr., vice chancellor for translational medicine and science at Rutgers Biomedical and Health Sciences and conducted through the Rutgers Institute for Translational Medicine and Science and the New Jersey Alliance for Clinical and Translational Science. To read the
full story
.
More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital are participating in a pioneering study.
Rutgers University announced today that it has launched the nation’s largest prospective study of health care workers exposed to COVID-19. The study includes a series of clinical trials that will explore new drug treatments, antibody testing, and long-term health tracking in the hope of providing insight into how to treat the disease and prevent its spread.
Read the full article
.
Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital Announce Submission of IND for a Phase 2 Study of EDP1815 in COVID-19 Patients.
Evelo Biosciences, Inc. (Nasdaq:
EVLO
), Rutgers University, and Robert Wood Johnson University Hospital announced the submission of an Investigational New Drug (IND) application for an Evelo-sponsored Phase 2 clinical study evaluating the safety and efficacy of EDP1815 for the treatment of hospitalized patients with newly diagnosed COVID-19. The study will be led by Reynold A. Panettieri, Jr., M.D., Vice Chancellor for Translational Medicine and Science at Rutgers Biomedical and Health Sciences and Professor of Medicine at Rutgers Robert Wood Johnson Medical School.
Learn more
.
Rutgers researchers propose treating COVID-19 patients with psoriasis drug
.
Scientists are researching if a drug that’s being tested to treat a skin condition can also help keep COVID-19 patients off ventilators. The drug, labeled as EDP1815, was being tested on psoriasis patients, but Dr. Reynold Panettieri, vice chancellor for translational medicine and science at Rutgers University, said it will now be tested on coronavirus patients who have pneumonia and inflammation of the lungs. To read the
full article
.
NSF RAPID grant awarded for study of how anxiety affects the spread of COVID-19 information.
Princeton researchers have been awarded a National Science Foundation RAPID grant to study how anxiety about COVID-19 influences how we learn and share information about the pandemic. The NSF’s Rapid Response Research (RAPID) program funds proposals that require quick-response research on disasters and unanticipated events.
Read the full article.
To learn more about funding opportunities and innovation challenges to assist the academic research community in mitigating COVID-19,
click here
.
|
|
Dismantling Systemic Racism: The End Game
Hosted by Dr. Qiana L. Brown, Assistant Professor Rutgers School of Social Work and Public Health; NJ ACTS Scholar in Clinical and Translational
|
|
THURSDAY, JUNE 18, 2020 | 3:15-4:45PM | #RACISMENDSHERE #DISMANTLESYSTEMICRACISM
|
|
Join this
Twitter Chat
to generate ideas and action steps to move society toward a plan to dismantle systemic racism. The chat will be hosted by Qiana L. Brown, PhD, MPH, LCSW Assistant Professor of Epidemiology and Maternal and Child Health, Rutgers School of Social Work and School of Public Health, Department of Urban-Global Public Health; NJ ACTS Scholar in Clinical and Translational Science. Panelists include:
- Dean Thomas A. LaVeist, PhD (@tlaveist) Tulane School of Public Health & Tropical Medicine and Weatherhead Presidential Chair in Health Equity
- Ayana Jordan, MD, PhD (@DrAyanaJordan) Associate Program Director, Yale Psychiatry Residency; Assistant Professor, Department of Psychiatry Yale University School of Medicine; Addiction Psychiatrist, Connecticut Mental Health Center
- Devin English, PhD (@devinsenglish) Assistant Professor, Rutgers School of Public Health
To learn how to create a twitter account,
click here
.
|
|
|
|
|
ScreenNJ 2020 Conference - “Collaboration is Key: Reducing the Burden of Colorectal and Lung Cancer in New Jersey”
The objectives of ScreenNJ are to increase screening for colorectal and lung cancer and to educate providers and staff in healthcare and community organizations about new and emerging best practices in cancer screening, early detection, and prevention.
- Thursday, June 25, 2020 from 2:00-3:00PM, “Understanding What’s New About Lung Cancer Screening & Integrating Smoking Cessation Into Community Education and Primary Care Practice Effectively”
- Thursday, June 25, 2020 from 3:00-4:00PM, “Working with ScreenNJ: Developing a Program, Applying for Funding, and Measuring Success”
|
|
Implementation Science Webinar
Monday, June 29, 2020, from 3:00-4:00PM
, join GMAP, to learn about NCI Implementation Science Programs, Funding Opportunities, and Researcher Experiences, Featuring:
- Gila Neta, PhD, MPP, Program Officer, National Cancer Institute, Division of Cancer Control and Population Sciences
- Shawna Hudson, PhD, Professor and Research Division Chief, Department of Family Medicine and Community Health; Director, Center of Advancing Research and Evaluation or Patient- Centered Care (CARE_PC), Rutgers Robert Wood Johnson Medical School; Co-Director of Community Engagement, NJ Alliance for Clinical and Translational Science (NJ ACTS)
- Rachel Shelton, ScD, MPH, Assistant Professor, Columbia University, Mailman School of Public Health, Department of Sociomedical Sciences; Associate Director of Community Engagement Core Resource, Columbia's Irving Institute for Clinical and Translational Research; Associate Director of Research, Lerner Center for Health Promotion
|
|
|
New Jersey Alliance for Clinical and Translational Science
An NCATS-funded CTSA Hub: UL1TR003017
|
|
|
|
|
|
|
